Eu Ivdd Eu Ivd Annex 2 List A On The Market 🇹🇼 Taiwan

HBV RealQuant™ PCR

General Biologicals Corporation · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
2
Countries
0
Notified Bodies
2

Basic Information

Primary DI
04712803530016
Basic UDI-DI Code
B-04712803530016
Reference
4HBPA2
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List A
Status
On The Market

Additional Description

HBV RealQuant™ PCR is an in vitro nucleic acid amplification diagnostic kit developed by General Biologicals Corporation, Taiwan. It is intended for quantitative detection of hepatitis B DNA (viral load) in human serum or plasma. HBV RealQuant™ PCR is not intended for use as a screening test for blood or blood products for the presence of HBV or as a diagnostic test to confirm the presence of HBV infection.

CND Nomenclature Codes

Code Description
W0105020299 HBV REAGENTS - OTHER

Certificates

Type Number
IVDD Annex IV Section 4 2116030DE08
IVDD Annex IV (excluding sections 4, 6) 2116030CE02

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List A) and regulation (EU IVDD).

View all